Literature DB >> 8627746

Persistent activation of NF-kappa B/Rel by human T-cell leukemia virus type 1 tax involves degradation of I kappa B beta.

L Good1, S C Sun.   

Abstract

Activation of the eukaryotic NF-kappaB/Rel transcription factors by various cytokines and mitogens is a transient event, reflecting the fact that these inducers trigger the degradation and resynthesis of the dynamic NF-kappaB/Rel inhibitor IkappaBalpha. However, the tax gene product of the human T-cell leukemia virus type 1 (HTLV-1) is known to induce the persistent nuclear expression of various NF-kappaB/Rel factors, especially the c-Rel proto-oncoprotein, although the underlying mechanism remains unclear. In the present study, we demonstrate that Tax induces the degradation Of IkappaBbeta, another NF-kappaB/Rel cytoplasmic inhibitor that differs from IkappaBalpha in signal responses. Unlike that observed with IkappaBalpha, the degradation Of IkappaBbeta is not associated with its rapid resynthesis, apparently because of the failure of Tax to stimulate IkappaBbeta gene transcription. Thus, expression of Tax in Jurkat T cells leads to the gradual depletion of IkappaBbeta, which is correlated with the induction of c-Rel-containing kappaB binding complexes. Remarkably, in the three HTLV-1-infected T-cell lines investigated, little or no detectable amount of IkappaBbeta was found. We further demonstrate that Tax is able to override the cytoplasmic retention of c-Rel by 1kappaBbeta in transiently transfected cells. Together, these studies suggest that Tax-mediated inactivation Of IkappaBbeta may play a role in the persistent nuclear expression of c-Rel induced by HTLV-I infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627746      PMCID: PMC190129     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I.

Authors:  M Siekevitz; M B Feinberg; N Holbrook; F Wong-Staal; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

2.  Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I.

Authors:  S L Cross; M B Feinberg; J B Wolf; N J Holbrook; F Wong-Staal; W J Leonard
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

3.  Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering.

Authors:  M Maruyama; H Shibuya; H Harada; M Hatakeyama; M Seiki; T Fujita; J Inoue; M Yoshida; T Taniguchi
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

4.  Cis-acting transcriptional regulatory sequences in the gibbon ape leukemia virus (GALV) long terminal repeat.

Authors:  N J Holbrook; A Gulino; F Ruscetti
Journal:  Virology       Date:  1987-03       Impact factor: 3.616

5.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes.

Authors:  S Z Salahuddin; P D Markham; F Wong-Staal; G Franchini; V S Kalyanaraman; R C Gallo
Journal:  Virology       Date:  1983-08       Impact factor: 3.616

7.  The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice.

Authors:  M Nerenberg; S H Hinrichs; R K Reynolds; G Khoury; G Jay
Journal:  Science       Date:  1987-09-11       Impact factor: 47.728

8.  A transgenic mouse model for human neurofibromatosis.

Authors:  S H Hinrichs; M Nerenberg; R K Reynolds; G Khoury; G Jay
Journal:  Science       Date:  1987-09-11       Impact factor: 47.728

9.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

10.  Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1.

Authors:  J Inoue; M Seiki; T Taniguchi; S Tsuru; M Yoshida
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  22 in total

1.  Phosphorylation of the human T-cell leukemia virus type 1 transactivator tax on adjacent serine residues is critical for tax activation.

Authors:  F Bex; K Murphy; R Wattiez; A Burny; R B Gaynor
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

2.  Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells.

Authors:  S Miyamoto; B J Seufzer; S D Shumway
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

3.  CD28 mediates a potent costimulatory signal for rapid degradation of IkappaBbeta which is associated with accelerated activation of various NF-kappaB/Rel heterodimers.

Authors:  E W Harhaj; S B Maggirwar; L Good; S C Sun
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

4.  Distinct functional properties of IkappaB alpha and IkappaB beta.

Authors:  K Tran; M Merika; D Thanos
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

5.  Alternative splicing variants of IkappaB beta establish differential NF-kappaB signal responsiveness in human cells.

Authors:  F Hirano; M Chung; H Tanaka; N Maruyama; I Makino; D D Moore; C Scheidereit
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

6.  Regulation of IkappaBbeta expression in testis.

Authors:  Lucy M Budde; Chun Wu; Christopher Tilman; Iris Douglas; Sankar Ghosh
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

Review 7.  Regulation of NF-kappaB by the HTLV-1 Tax protein.

Authors:  X H Li; R B Gaynor
Journal:  Gene Expr       Date:  1999

8.  Salicylates inhibit flavivirus replication independently of blocking nuclear factor kappa B activation.

Authors:  C L Liao; Y L Lin; B C Wu; C H Tsao; M C Wang; C I Liu; Y L Huang; J H Chen; J P Wang; L K Chen
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

9.  Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases.

Authors:  R Geleziunas; S Ferrell; X Lin; Y Mu; E T Cunningham; M Grant; M A Connelly; J E Hambor; K B Marcu; W C Greene
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha.

Authors:  L R You; C M Chen; Y H Lee
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.